MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
LENSAR Operating Income 2011-2026 | LNSR
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income LENSAR
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -10.7 M | -12.2 M | -20.2 M | -19.7 M | -18.5 M | -12.7 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -10.7 M | -20.2 M | -15.7 M |
Quarterly Operating Income LENSAR
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.58 M | -6.29 M | -5.79 M | - | -1.24 M | -5.28 M | -2.85 M | - | -2.04 M | -2.87 M | -4.36 M | - | -4.08 M | -6.8 M | -6.68 M | - | -6.16 M | -4.38 M | -5.2 M | - | -4.71 M | -3.84 M | -3.1 M | - | -5.34 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -1.24 M | -7.58 M | -4.66 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Delcath Systems
DCTH
|
660 K | $ 9.19 | 2.28 % | $ 329 M |  USA |
 |
BioSig Technologies
BSGM
|
-12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
-11.7 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
Second Sight Medical Products
EYES
|
-24.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
Helius Medical Technologies
HSDT
|
-12.4 M | $ 2.14 | 6.47 % | $ 1.3 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
28.4 M | $ 9.54 | - | $ 735 M | USA |
 |
Inogen
INGN
|
-30.2 M | $ 6.41 | 1.42 % | $ 171 M | USA |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
IRIDEX Corporation
IRIX
|
-10 M | $ 1.33 | -1.48 % | $ 21.5 M | USA |
 |
IRadimed Corporation
IRMD
|
26.1 M | $ 101.59 | 0.62 % | $ 1.29 B | USA |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
 |
LivaNova PLC
LIVN
|
199 M | $ 63.64 | 1.99 % | $ 3.47 B |  Britain |
 |
CONMED Corporation
CNMD
|
103 M | $ 37.07 | 1.38 % | $ 1.15 B | USA |
 |
NanoVibronix
NAOV
|
-3.58 M | - | - | $ 1.08 M | USA |
 |
Electromed
ELMD
|
9.66 M | $ 24.71 | 0.02 % | $ 209 M | USA |
 |
Medtronic PLC
MDT
|
5.96 B | $ 87.73 | 1.33 % | $ 113 B | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
MiMedx Group
MDXG
|
63.9 M | $ 4.11 | -0.61 % | $ 607 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-16.8 M | $ 0.67 | -4.18 % | $ 36.5 M | USA |
 |
Aethlon Medical
AEMD
|
-9.34 M | $ 2.38 | 10.12 % | $ 3.71 M | USA |
 |
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | USA |
 |
Orthofix Medical
OFIX
|
-81.4 M | $ 11.86 | 1.19 % | $ 470 M |  Curacao |
 |
InspireMD
NSPR
|
-49.6 M | $ 1.76 | -1.68 % | $ 113 M |  Israel |
 |
AdaptHealth Corp.
AHCO
|
90.9 M | $ 11.37 | -1.0 % | $ 1.54 B | USA |
 |
Penumbra
PEN
|
189 M | $ 336.27 | 0.63 % | $ 13.1 B | USA |
 |
Myomo
MYO
|
-14.4 M | $ 0.69 | -0.83 % | $ 28.9 M | USA |
 |
Insulet Corporation
PODD
|
474 M | $ 217.14 | -3.71 % | $ 15.3 B | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
-56.7 M | $ 2.3 | -4.38 % | $ 135 M | Israel |
 |
Invacare Corporation
IVC
|
-80.5 M | - | - | $ 24.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-20.5 M | $ 3.72 | -4.86 % | $ 139 M |  France |
 |
Profound Medical Corp.
PROF
|
-30.3 M | $ 5.9 | 14.47 % | $ 180 M | Canada |
 |
OrthoPediatrics Corp.
KIDS
|
-39.2 M | $ 16.33 | 2.64 % | $ 383 M | USA |
 |
Quanterix Corporation
QTRX
|
-126 M | $ 3.9 | 2.09 % | $ 166 M | USA |
 |
Outset Medical
OM
|
-66.7 M | $ 3.49 | -1.13 % | $ 53.1 K | USA |